Effects of creatine treatment on the survival of dopaminergic neurons in cultured fetal ventral mesencephalic tissue

Neuroscience

Volumn 133, Issue 3, 2005, Pages 701-713

  Andres, R H ^a   Huber, A W ^a   Schlattner, U ^b   Perez Bouza A ^a   Krebs, S H ^a   Seiler, R W ^a   Wallimann, T ^b   Widmer, H R ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b ETH ZURICH   (Switzerland)

Author keywords

Creatine kinase; Neuroprotection; Parkinson's disease; Rat cell cultures; Tyrosine hydroxylase; Ventral mesencephalon

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CREATINE; GLUCOSE; OXIDOPAMINE;

ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CELL SIZE; CELL STRUCTURE; CELL SURVIVAL; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG EFFECT; FETUS; GLUCOSE BRAIN LEVEL; GLYCOLYSIS; MESENCEPHALON; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

1-METHYL-4-PHENYLPYRIDINIUM; ANIMALS; CELL SHAPE; CELL SURVIVAL; CELLS, CULTURED; CREATINE; CREATINE KINASE; CREATINE KINASE, BB FORM; CREATINE KINASE, MITOCHONDRIAL FORM; CREATININE; DOPAMINE; DRUG INTERACTIONS; FEMALE; ISOENZYMES; MESENCEPHALON; NEURONS; OXIDOPAMINE; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY; SYMPATHOLYTICS; TYROSINE 3-MONOOXYGENASE;

EID: 20444382385     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2005.03.004     Document Type: Article

References (88)

1. K.H. Adcock, J. Nedelcu, T. Loenneker, E. Martin, T. Wallimann, B.P. Wagner Neuroprotection of creatine supplementation in neonatal rats with transient cerebral hypoxia-ischemia Dev Neurosci 24 2002 382 388
2. A. Ames CNS energy metabolism as related to function Brain Res Brain Res Rev 34 2000 42 68
3. O.A. Andreassen, A. Dedeoglu, R.J. Ferrante, B.G. Jenkins, K.L. Ferrante, M. Thomas, A. Friedlich, S.E. Browne, G. Schilling, D.R. Borchelt, S.M. Hersch, C.A. Ross, M.F. Beal Creatine increase survival and delays motor symptoms in a transgenic animal model of Huntington's disease Neurobiol Dis 8 2001 479 491
4. O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, K.L. Ferrante, M.B. Bogdanov, D. Kaddurah, M.F. Beal Increases in cortical glutamate concentrations in transgenic amyotrophic lateral sclerosis mice are attenuated by creatine supplementation J Neurochem 77 2001 383 390
5. A. Bender, D.P. Auer, T. Merl, R. Reilmann, P. Saemann, A. Yassouridis, J. Bender, A. Weindl, M. Dose, T. Gasser, T. Klopstock Creatine supplementation lowers brain glutamate levels in Huntington's disease J Neurol 252 2005 36 41
6. J. Bilsland, S. Roy, S. Xanthoudakis, D.W. Nicholson, Y. Han, E. Grimm, F. Hefti, S.J. Harper Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons J Neurosci 22 2002 2637 2649
7. C.V. Borlongan, P.R. Sanberg, T.B. Freeman Neural transplantation for neurodegenerative disorders Lancet 353 Suppl 1 1999 SI29 SI30
8. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
9. O. Braissant, H. Henry, M. Loup, B. Eilers, C. Bachmann Endogenous synthesis and transport of creatine in the rat brain an in situ hybridization study Brain Res Mol Brain Res 86 2001 193 201
10. D. Brdiczka, G. Beutner, A. Ruck, M. Dolder, T. Wallimann The molecular structure of mitochondrial contact sites. Their role in regulation of energy metabolism and permeability transition Biofactors 8 1998 235 242
11. G.J. Brewer, T.W. Wallimann Protective effect of the energy precursor creatine against toxicity of glutamate and beta-amyloid in rat hippocampal neurons J Neurochem 74 2000 1968 1978
12. N. Brustovetsky, T. Brustovetsky, J.M. Dubinsky On the mechanisms of neuroprotection by creatine and phosphocreatine J Neurochem 76 2001 425 434
13. L. Chen, R. Roberts, D.L. Friedman Expression of brain-type creatine kinase and ubiquitous mitochondrial creatine kinase in the fetal rat brain evidence for a nuclear energy shuttle J Comp Neurol 363 1995 389 401
14. B. Cheng, M.P. Mattson NT-3 and BDNF protect CNS neurons against metabolic/excitotoxic insults Brain Res 640 1994 56 67
15. W.S. Choi, S.Y. Yoon, T.H. Oh, E.J. Choi, K.L. O'Malley, Y.J. Oh Two distinct mechanisms are involved in 6-hydroxydopamine- and MPP+-induced dopaminergic neuronal cell death role of caspases, ROS, and JNK J Neurosci Res 57 1999 86 94
16. R.J. Corbett, A.R. Laptook Age-related changes in swine brain creatine kinase-catalyzed 31P exchange measured in vivo using 31P NMR magnetization transfer J Cereb Blood Flow Metab 14 1994 1070 1077
17. P. Dechent, P.J. Pouwels, B. Wilken, F. Hanefeld, J. Frahm Increase of total creatine in human brain after oral supplementation of creatine-monohydrate Am J Physiol 277 1999 R698 R704
18. D.E. Decker, J.S. Althaus, S.E. Buxser, P.F. VonVoigtlander, P.L. Ruppel Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine Res Commun Chem Pathol Pharmacol 79 1993 195 208
19. M. Dolder, B. Walzel, O. Speer, U. Schlattner, T. Wallimann Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation J Biol Chem 278 2003 17760 17766
20. Y. Dunant, F. Loctin, J. Marsal, D. Muller, A. Parducz, X. Rabasseda Energy metabolism and quantal acetylcholine release effects of botulinum toxin, 1-fluoro-2,4-dinitrobenzene, and diamide in the Torpedo electric organ J Neurochem 50 1988 431 439
21. S. Dunnett, A. Björklund Staging and dissection of rat embryos S. Dunnett A. Björklund Neural transplantation, a practical approach 1992 Oxford University Press Oxford 1 19
22. J.W. Fawcett, R.A. Barker, S.B. Dunnett Dopaminergic neuronal survival and the effects of bFGF in explant, three dimensional and monolayer cultures of embryonic rat ventral mesencephalon Exp Brain Res 106 1995 275 282
23. R.J. Ferrante, O.A. Andreassen, B.G. Jenkins, A. Dedeoglu, S. Kuemmerle, J.K. Kubilus, R. Kaddurah-Daouk, S.M. Hersch, M.F. Beal Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease J Neurosci 20 2000 4389 4397
24. C.R. Freed, P.E. Greene, R.E. Breeze, W.Y. Tsai, W. DuMouchel, R. Kao, S. Dillon, H. Winfield, S. Culver, J.Q. Trojanowski, D. Eidelberg, S. Fahn Transplantation of embryonic dopamine neurons for severe Parkinson's disease N Engl J Med 344 10 2001 710 719
25. C.R. Freed, M.A. Leehey, M. Zawada, K. Bjugstad, L. Thompson, R.E. Breeze Do patients with Parkinson's disease benefit from embryonic dopamine cell transplantation? J Neurol 250 Suppl 3 2003 III44 III46
26. Y. Glinka, M. Gassen, M.B. Youdim Mechanism of 6-hydroxydopamine neurotoxicity J Neural Transm Suppl 50 1997 55 66
27. M. Gu, J.M. Cooper, J.W. Taanman, A.H. Schapira Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease Ann Neurol 44 1998 177 186
28. M. Gu, A.D. Owen, S.E. Toffa, J.M. Cooper, D.T. Dexter, P. Jenner, C.D. Marsden, A.H. Schapira Mitochondrial function, GSH and iron in neurodegeneration and Lewy body diseases J Neurol Sci 158 1998 24 29
29. M.L. Guerrero, J. Beron, B. Spindler, P. Groscurth, T. Wallimann, F. Verrey Metabolic support of Na+ pump in apically permeabilized A6 kidney cell epithelia role of creatine kinase Am J Physiol 272 1997 C697 C706
30. M.L. Guerrero-Ontiveros, T. Wallimann Creatine supplementation in health and disease. Effects of chronic creatine ingestion in vivo: down-regulation of the expression of creatine transporter isoforms in skeletal muscle Mol Cell Biochem 184 1998 427 437
31. W. Hemmer, I. Riesinger, T. Wallimann, H.M. Eppenberger, A.F. Quest Brain-type creatine kinase in photoreceptor cell outer segments role of a phosphocreatine circuit in outer segment energy metabolism and phototransduction J Cell Sci 106 Pt 2 1993 671 683
32. W. Hemmer, T. Wallimann Functional aspects of creatine kinase in brain Dev Neurosci 15 1993 249 260
33. D. Holtzman, J.E. Olson, H. Nguyen, J. Hsu, N. Lewiston Brain cellular and mitochondrial respiration in media of altered pH Metab Brain Dis 2 1987 127 137
34. D. Holtzman, M. Tsuji, T. Wallimann, W. Hemmer Functional maturation of creatine kinase in rat brain Dev Neurosci 15 1993 261 270
35. B. Janetzky, S. Hauck, M.B. Youdim, P. Riederer, K. Jellinger, F. Pantucek, R. Zochling, K.W. Boissl, H. Reichmann Unaltered aconitase activity, but decreased complex I activity in substantia nigra pars compacta of patients with Parkinson's disease Neurosci Lett 169 1994 126 128
36. F. Jensen, M. Tsuji, M. Offutt, I. Firkusny, D. Holtzman Profound, reversible energy loss in the hypoxic immature rat brain Brain Res Dev Brain Res 73 1993 99 105
37. W.F. Kaemmerer, C.M. Rodrigues, C.J. Steer, W.C. Low Creatine- supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype Neuroscience 103 2001 713 724
38. P. Klivenyi, R.J. Ferrante, R.T. Matthews, M.B. Bogdanov, A.M. Klein, O.A. Andreassen, G. Mueller, M. Wermer, R. Kaddurah-Daouk, M.F. Beal Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis Nat Med 5 1999 347 350
39. U.K. Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4 Nature 227 1970 680 685
40. A.E. Lang, A.M. Lozano Parkinson's disease. First of two parts N Engl J Med 339 1998 1044 1053
41. A.E. Lang, A.M. Lozano Parkinson's disease. Second of two parts N Engl J Med 339 1998 1130 1143
42. J.J. Lemasters, T. Qian, C.A. Bradham, D.A. Brenner, W.E. Cascio, L.C. Trost, Y. Nishimura, A.L. Nieminen, B. Herman Mitochondrial dysfunction in the pathogenesis of necrotic and apoptotic cell death J Bioenerg Biomembr 31 1999 305 319
43. J. Lotharius, L.L. Dugan, K.L. Malley Distinct mechanisms underlie neurotoxin-mediated cell death in cultured dopaminergic neurons J Neurosci 19 1999 1284 1293
44. V.M. Mann, J.M. Cooper, D. Krige, S.E. Daniel, A.H. Schapira, C.D. Marsden Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease Brain 115 Pt 2 1992 333 342
45. P. Manos, G.K. Bryan, J. Edmond Creatine kinase activity in postnatal rat brain development and in cultured neurons, astrocytes, and oligodendrocytes J Neurochem 56 1991 2101 2107
46. A.M. Marini, T.S. Nowak Metabolic effects of 1-methyl-4-phenylpyridinium (MPP(+)) in primary neuron cultures J Neurosci Res 62 2000 814 820
47. R.T. Matthews, R.J. Ferrante, P. Klivenyi, L. Yang, A.M. Klein, G. Mueller, R. Kaddurah-Daouk, M.F. Beal Creatine and cyclocreatine attenuate MPTP neurotoxicity Exp Neurol 157 1999 142 149
48. R.T. Matthews, L. Yang, B.G. Jenkins, R.J. Ferrante, B.R. Rosen, R. Kaddurah-Daouk, M.F. Beal Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease J Neurosci 18 1998 156 163
49. M.P. Mattson, W.A. Pedersen, W. Duan, C. Culmsee, S. Camandola Cellular and molecular mechanisms underlying perturbed energy metabolism and neuronal degeneration in Alzheimer's and Parkinson's diseases Ann N Y Acad Sci 893 1999 154 175
50. E. Mazzio, K.F. Soliman D-(+)-glucose rescue against 1-methyl-4- phenylpyridinium toxicity through anaerobic glycolysis in neuroblastoma cells Brain Res 962 2003 48 60
51. K.S. McNaught, P.A. Carrupt, C. Altomare, S. Cellamare, A. Carotti, B. Testa, P. Jenner, C.D. Marsden Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease Biochem Pharmacol 56 1998 921 933
52. T. Michaelis, M. Wick, H. Fujimori, A. Matsumura, J. Frahm Proton MRS of oral creatine supplementation in rats. Cerebral metabolite concentrations and ischemic challenge NMR Biomed 12 1999 309 314
53. P.P. Michel, B.K. Dandapani, B. Knusel, R. Sanchez, F. Hefti Toxicity of 1-methyl-4-phenylpyridinium for rat dopaminergic neurons in culture selectivity and irreversibility J Neurochem 54 1990 1102 1109
54. P.P. Michel, F. Hefti Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture J Neurosci Res 26 1990 428 435
55. Y. Mizuno, S. Ikebe, N. Hattori, H. Nakagawa, H. Mochizuki, M. Tanaka, T. Ozawa Role of mitochondria in the etiology and pathogenesis of Parkinson's disease Biochim Biophys Acta 1271 1995 265 274
56. S.R. Nash, B. Giros, S.F. Kingsmore, J.M. Rochelle, S.T. Suter, P. Gregor, M.F. Seldin, M.G. Caron Cloning, pharmacological characterization, and genomic localization of the human creatine transporter Receptors Channels 2 1994 165 174
57. W.I. Norwood, J.S. Ingwall, C.R. Norwood, E.T. Fossel Developmental changes of creatine kinase metabolism in rat brain Am J Physiol 244 1983 C205 C210
58. E. O'Gorman, G. Beutner, M. Dolder, A.P. Koretsky, D. Brdiczka, T. Wallimann The role of creatine kinase in inhibition of mitochondrial permeability transition FEBS Lett 414 1997 253 257
59. K. Plaschke, S.W. Yun, E. Martin, S. Hoyer, H.J. Bardenheuer Linear relation between cerebral phosphocreatine concentration and memory capacities during permanent brain vessel occlusions in rats Ann N Y Acad Sci 903 2000 299 306
60. M.D. Saltarelli, A.L. Bauman, K.R. Moore, C.C. Bradley, R.D. Blakely Expression of the rat brain creatine transporter in situ and in transfected HeLa cells Dev Neurosci 18 1996 524 534
61. A. Sauter, M. Rudin Determination of creatine kinase kinetic parameters in rat brain by NMR magnetization transfer. Correlation with brain function J Biol Chem 268 1993 13166 13171
62. A.H. Schapira, J.M. Cooper, D. Dexter, J.B. Clark, P. Jenner, C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease J Neurochem 54 1990 823 827
63. G.S. Schierle, P. Brundin Excitotoxicity plays a role in the death of tyrosine hydroxylase- immunopositive nigral neurons cultured in serum-free medium Exp Neurol 157 1999 338 348
64. U. Schlattner, N. Mockli, O. Speer, S. Werner, T. Wallimann Creatine kinase and creatine transporter in normal, wounded, and diseased skin J Invest Dermatol 118 2002 416 423
65. D.A. Shear, K.L. Haik, G.L. Dunbar Creatine reduces 3-nitropropionic- acid-induced cognitive and motor abnormalities in rats Neuroreport 11 2000 1833 1837
66. J.P. Sheehan, R.H. Swerdlow, W.D. Parker, S.W. Miller, R.E. Davis, J.B. Tuttle Altered calcium homeostasis in cells transformed by mitochondria from individuals with Parkinson's disease J Neurochem 68 1997 1221 1233
67. D.K. Simon, R. Mayeux, K. Marder, N.W. Kowall, M.F. Beal, D.R. Johns Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson's disease Neurology 54 2000 703 709
68. E.A. Sistermans, K. de, W. Peters, L.A. Ginsel, P.H. Jap, B. Wieringa Tissue- and cell-specific distribution of creatine kinase B a new and highly specific monoclonal antibody for use in immunohistochemistry Cell Tissue Res 280 1995 435 446
69. C. Spenger, L. Studer, L. Evtouchenko, M. Egli, J.M. Burgunder, R. Markwalder, R.W. Seiler Long-term survival of dopaminergic neurones in free-floating roller tube cultures of human fetal ventral mesencephalon J Neurosci Methods 54 1994 63 73
70. L. Studer, C. Spenger, R.W. Seiler, C.A. Altar, R.M. Lindsay, C. Hyman Comparison of the effects of the neurotrophins on the morphological structure of dopaminergic neurons in cultures of rat substantia nigra Eur J Neurosci 7 1995 223 233
71. P.G. Sullivan, J.D. Geiger, M.P. Mattson, S.W. Scheff Dietary supplement creatine protects against traumatic brain injury Ann Neurol 48 5 2000 723 729
72. P. Thajeb, Z.D. Ling, E.D. Potter, P.M. Carvey The effects of storage conditions and trophic supplementation on the survival of fetal mesencephalic cells Cell Transplant 6 1997 297 307
73. C.C. Toner, J.A. Stamford Effects of metabolic alterations on dopamine release in an in vitro model of neostriatal ischaemia Brain Res Bull 48 1999 395 399
74. T. Wallimann, M. Dolder, U. Schlattner, M. Eder, T. Hornemann, E. O'Gorman, A. Ruck, D. Brdiczka Some new aspects of creatine kinase (CK) compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology Biofactors 8 1998 229 234
75. T. Wallimann, W. Hemmer Creatine kinase in non-muscle tissues and cells Mol Cell Biochem 133-134 1994 193 220
76. T. Wallimann, T. Schnyder, J. Schlegel, M. Wyss, G. Wegmann, A.M. Rossi, W. Hemmer, H.M. Eppenberger, A.F. Quest Subcellular compartmentation of creatine kinase isoenzymes, regulation of CK and octameric structure of mitochondrial CK important aspects of the phosphoryl-creatine circuit Prog Clin Biol Res 315 1989 159 176
77. T. Wallimann, M. Wyss, D. Brdiczka, K. Nicolay, H.M. Eppenberger Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands the 'phosphocreatine circuit' for cellular energy homeostasis Biochem J 281 Pt 1 1992 21 40
78. T.S. Whittingham, P. Lipton Cerebral synaptic transmission during anoxia is protected by creatine J Neurochem 37 1981 1618 1621
79. H.R. Widmer, F. Hefti Neurotrophin-4/5 promotes survival and differentiation of rat striatal neurons developing in culture Eur J Neurosci 6 1994 1669 1679
80. H.R. Widmer, B. Schaller, M. Meyer, R.W. Seiler Glial cell line-derived neurotrophic factor stimulates the morphological differentiation of cultured ventral mesencephalic calbindin- and calretinin-expressing neurons Exp Neurol 164 2000 71 81
81. B. Wilken, J.M. Ramirez, I. Probst, D.W. Richter, F. Hanefeld Creatine protects the central respiratory network of mammals under anoxic conditions Pediatr Res 43 1998 8 14
82. B. Wilken, J.M. Ramirez, I. Probst, D.W. Richter, F. Hanefeld Anoxic ATP depletion in neonatal mice brainstem is prevented by creatine supplementation Arch Dis Child Fetal Neonatal Ed 82 2000 F224 F227
83. C. Winkler, D. Kirik, A. Bjorklund Cell transplantation in Parkinson's disease how can we make it work? Trends Neurosci 28 2005 86 92
84. D.T. Woznicki, J.B. Walker Formation of a supplemental long time-constant reservoir of high energy phosphate by brain in vivo and in vitro and its reversible depletion by potassium depolarization J Neurochem 33 1979 75 80
85. D.T. Woznicki, J.B. Walker Utilization of the synthetic phosphagen cyclocreatine phosphate by a simple brain model during stimulation by neuroexcitatory amino acids J Neurochem 50 1988 1640 1647
86. M. Wyss, R. Kaddurah-Daouk Creatine and creatinine metabolism Physiol Rev 80 2000 1107 1213
87. J. Zhang, J.O. Price, D.G. Graham, T.J. Montine Secondary excitotoxicity contributes to dopamine-induced apoptosis of dopaminergic neuronal cultures Biochem Biophys Res Commun 248 1998 812 816
88. S. Zhu, M. Li, B.E. Figueroa, A. Liu, I.G. Stavrovskaya, P. Pasinelli, M.F. Beal, R.H. Brown Jr, B.S. Kristal, R.J. Ferrante, R.M. Friedlander Prophylactic creatine administration mediates neuroprotection in cerebral ischemia in mice J Neurosci 24 2004 5909 5912